DRKS00024819
Completed
未知
Prospective, monocentric clinical study about the effect of a novel technique for mucus mobilization on lung function, mucus viscosity and diaphragmatic mobility in cystic fibrosis patients - SekMobi-1
lm University Medical Center0 sites21 target enrollmentApril 8, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- E84.0
- Sponsor
- lm University Medical Center
- Enrollment
- 21
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •diagnosed cystic fibrosis
Exclusion Criteria
- •\- acute infection
- •\- reduced general condition
- •\- massive hemoptysis within the last 4 weeks
- •\- pneumothorax within the last 6 weeks
- •\- uncontrolled asthmatic symptoms
- •\- unstable cardiovascular disease
- •\- unstable pulmonary situation with dyspnea
- •\- pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Clinical study ofacne mastitisITMCTR2200006068Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine
Completed
Not Applicable
Prospective, randomized, monocentric study for the determination of device-related dead spaces under controlled ventilation under general anesthesiaSpine operations in prone positionDRKS00015797St. Josef- und St. Elisabeth- Hospital gGmbH Klinik für Anästhesiologie und operative Intensivmedizin34
Completed
Not Applicable
Prospective, randomized, monocentric study for the determination of device-related dead spaces in the MIRUS-System under controlled ventilation under general anesthesiaGeneral anaesthesia for orthopaedic surgeryJ80J44Adult respiratory distress syndromeOther chronic obstructive pulmonary diseaseDRKS00021648Katholisches Klinikum gGmbH, Klinik für Anästhesiologie und operative Intensivmedizin40
Not yet recruiting
Not Applicable
A prospective, single-center investigation of the safety and feasibility of a novel Microwave Ablation SystemC34C78.0Malignant neoplasm of bronchus and lungSecondary malignant neoplasm of lungDRKS00032463Intuitive Surgical30
Active, not recruiting
Phase 1
Study to investigate the effect of riociguat on right heart size and function in pulmonary hypertensioSymptomatic pulmonary arterial hypertension with a mean pulmonary artery pressure >20 mmHg and pulmonary vascular resistance =2 Wood Units, pulmonary arterial wedge pressure =15 mmHg (Group I / Nice Clinical Classification of Pulmonary Hypertension (PH)) or CTEPH (Group IV) with hemodynamics as stated above defined as inoperable measured at least 3 months after start of full anticoagulation or with persisting or recurrent PH after pulmonary endarterectomy at least 6 months after surgeryMedDRA version: 20.0Level: HLTClassification code 10037401Term: Pulmonary hypertensionsSystem Organ Class: 100000004855Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-005462-34-DEThoraxklinik Heidelberg gGmbH30